(Q40095273)

English

Construction and biological characterization of artificial recombinants between a wild type flavivirus (Kunjin) and a live chimeric flavivirus vaccine (ChimeriVax-JE).

scientific article published on 27 July 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Construction and biological characterization of artificial recombinants between a wild type flavivirus (Kunjin) and a live chimeric flavivirus vaccine (ChimeriVax-JE). (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Alexander A. Khromykh

9

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Thomas P. Monath

10

object named as

Thomas P Monath

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Farshad Guirakhoo

11

object named as

Farshad Guirakhoo

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

author name string

Konstantin V Pugachev

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Julia Schwaiger

2

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Nathan Brown

3

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Zhen-xi Zhang

4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

John Catalan

5

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Frederick S Mitchell

6

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Simeon W Ocran

7

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Alexander A Rumyantsev

8

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

language of work or name

0 references

publication date

27 July 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

37-38

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

6661-6671

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis anti

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

A live, attenuated recombinant West Nile virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Traditional and novel approaches to flavivirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

New developments in flavivirus vaccines with special attention to yellow fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Live flavivirus vaccines: reasons for caution

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Arguments for live flavivirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Arguments for live flavivirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Arguments for live flavivirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Recombination and flavivirus vaccines: a commentary

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Phylogenetic evidence for recombination in dengue virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Widespread intra-serotype recombination in natural populations of dengue virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

The extent of homologous recombination in members of the genus Flavivirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Diversity and evolution of the envelope gene of dengue virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Molecular and Functional Analyses of Kunjin Virus Infectious cDNA Clones Demonstrate the Essential Roles for NS2A in Virus Assembly and for a Nonconservative Residue in NS3 in RNA Replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Heterogeneous nature of the genome of the ARILVAX yellow fever 17D vaccine revealed by consensus sequencing

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Loss of dimerisation of the nonstructural protein NS1 of Kunjin virus delays viral replication and reduces virulence in mice, but still allows secretion of NS1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

West Nile Virus Infection in the Golden Hamster (Mesocricetus auratus): A Model for West Nile Encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Attenuation of the Langat tick-borne flavivirus by chimerization with mosquito-borne flavivirus dengue type 4

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Essential role of cyclization sequences in flavivirus RNA replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Genetic variation in the 3' non-coding region of dengue viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Fine Mapping of a cis-Acting Sequence Element in Yellow Fever Virus RNA That Is Required for RNA Replication and Cyclization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Long-Range RNA-RNA Interactions Circularize the Dengue Virus Genome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Experimental infection of Culex annulirostris, Culex gelidus, and Aedes vigilax with a yellow fever/Japanese encephalitis virus vaccine chimera (ChimeriVax-JE).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Growth characteristics of the veterinary vaccine candidate ChimeriVax-West Nile (WN) virus in Aedes and Culex mosquitoes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Analysis of the replication kinetics of the ChimeriVax-DEN 1, 2, 3, 4 tetravalent virus mixture in Aedes aegypti by real-time reverse transcriptase-polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

West Nile virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

Growth characteristics of the chimeric Japanese encephalitis virus vaccine candidate, ChimeriVax-JE (YF/JE SA14--14--2), in Culex tritaeniorhynchus, Aedes albopictus, and Aedes aegypti mosquitoes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2007.07.016

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40095273&oldid=2141271720"